Background: Despite decades of public education about dire consequences of prenatal alcohol exposure (PAE), drinking alcohol during pregnancy remains prevalent. As high as 40% of live-born infants exposed to alcohol during gestation and diagnosed with fetal alcohol syndrome have congenital heart defects that can be life-threatening. In animal models, the methyl donor betaine, found in foods such as wheat bran, quinoa, beets, and spinach, ameliorated neurobehavioral deficits associated with PAE, but effects on heart development are unknown.
M ATERNAL ALCOHOL CONSUMPTION during pregnancy remains a prevalent problem in the North America, even with the widespread and long-standing understanding that prenatal alcohol exposure (PAE) at any stage of pregnancy is harmful to the developing embryo and fetus. A recent survey from the Centers for Disease Control and Prevention (CDC) reported that 10% of pregnant women in the United States drink alcohol, while 3% engage in binge drinking (Tan et al., 2015) . The prevalence of fetal alcohol spectrum disorders (FASD), an umbrella term encompassing all alcohol-related defects, ranges from 24 to 48 cases per 1,000 children (May et al., 2014) , but these numbers are often higher in certain communities and are suspected to be underdiagnosed. Alcohol-associated neurodevelopmental and craniofacial defects are well characterized (Williams and Smith, 2015) , and reviews of the literature have also revealed a substantial number of cardiac defects in patients with FASD (Burd et al., 2007; Popova et al., 2016) . When Popova and colleagues (2016) conducted a meta-analysis, they noted that the prevalence of cardiac defects including valvuloseptal and outflow anomalies was as high as 40 to 50% in patients diagnosed with fetal alcohol syndrome (FAS), the most severely affected of the FASD spectrum.
In previous studies, we established a model of PAE in an avian model where binge-like concentrations of alcohol were introduced at gastrulation stages (Karunamuni et al., 2014 (Karunamuni et al., , 2015 . This PAE model is similar to that used by others in which fertilized chicken eggs were injected with ethanol (EtOH) (Serrano et al., 2010; Smith, 2008) and phenocopies findings from PAE models in other animal models as well as characteristics of FAS individuals (Suttie et al., 2013; Wilson and Cudd, 2011) . This stage is equivalent to the third week of pregnancy when a woman may not have recognized nor confirmed that she is pregnant. Alcohol exposure severely reduced survival and increased the frequency of defects of the head and body (failure of head and body wall closure) in our avian model, and contributed to the development of a spectrum of FASD-related cardiac anomalies that would require surgical correction and long-term medical care in human patients. In theory, FASD-associated birth defects are 100% preventable as long as women abstain from alcohol consumption either while trying to conceive or during pregnancy, as recommended by the CDC and American Academy of Pediatrics (Green et al., 2016; Williams and Smith, 2015) . However, this may not be practical especially as drinking rates among pregnant women have remained constant over the last few decades (Denny et al., 2009; Marchetta et al., 2012; Tan et al., 2015) despite our expanding knowledge of the inherent risks that alcohol can pose to the developing fetus. Therefore, in addition to continuing campaigns to educate the public on the hazards of PAE, it is crucial that we continue to identify safe, effective supplements, and/or vitamins that can prevent alcohol-associated defects.
Folate or folic acid is already present in prenatal supplements and as a food supplement in North America for protection against congenital neural tube defects, including those associated with alcohol exposure (Bailey et al., 2015; Serrano et al., 2010; Shi et al., 2014) . However, current recommended supplement levels may not be sufficient to prevent alcohol-induced congenital heart defects (CHDs) (Huhta and Linask, 2015) . Increased folate intake could be problematic in some patient populations as it has been linked to higher cancer risks (Cole, 2007; Ebbing et al., 2009 ). Another consideration is that certain women may not be responsive to folate supplementation, especially if they carry gene variants, such as those found in the gene for formethylenetetrahydrofolate reductase (MTHFR), an enzyme involved in folic acid metabolism. The variant C677T reduces enzyme activity as much as 30%, and its frequency can be as high as 20% in certain populations (Botto and Yang, 2000) . Thus, it would be beneficial to identify alternative low-dose supplements in preventing birth defects including CHDs.
Potential candidates include choline and its metabolite betaine, which, like folate, functions as a methyl donor in the methionine-homocysteine cycle (Fig. 1) , and are found naturally in foods such as liver, broccoli, spinach, beets, shrimp, and quinoa (Craig, 2004; Young et al., 2014) . Choline plays a role in several processes, including neurotransmission (via acetylcholine), cell membrane integrity (as phosphatidylcholine), and methyl group donation via its metabolite betaine (Young et al., 2014) . A recent national survey (Zeisel and da Costa, 2009) found that <10% of the U.S. population, including pregnant women, are getting their adequate intake of choline (450 mg/d) despite the fact that the metabolic demand for choline is increased during pregnancy especially in relation to fetal brain development (Zeisel, 2005) . There is no recommended daily dose for betaine, but as a methyl donor, it serves vital purposes. Among the many roles for betaine, it donates methyl groups for the metabolism of homocysteine to methionine, an important step in the progression of the 1-carbon cycle which methylates DNA and proteins, and thus regulates the expression of genes that are crucial for embryogenesis (Miller, 2003) .
It has already been established that PAE can alter the DNA methylation program and 1-carbon metabolism in mouse models (Liu et al., 2009; Zhou et al., 2011; Ngai et al., 2015) , which could contribute to abnormal fetal development. Using methyl donors such as choline and betaine in alcohol exposure models has already shown great promise in alleviating associated anomalies. Bekdash and colleagues (2013) showed that gestational choline supplementation in rats prevented neuronal damage induced by alcohol, while pre-or perinatal choline ameliorated behavioral and learning deficits in a PAE rat model (Ryan et al., 2008; Thomas et al., 2004 Thomas et al., , 2010 . Prenatal betaine supplementation also protected against alcohol-related neurodegeneration in rat pups (Kusat Ol et al., 2016) , and coculture with betaine reduced alcoholinduced apoptosis in cultures of neural crest cells (Wang and Bieberich, 2010) , which are thought to be severely impacted by fetal alcohol exposure (Smith et al., 2014) . However, detailed analysis of the effects of such supplementation on cardiac morphogenesis is sadly lacking, which we will address in this study. Previously in our model of PAE, survival rates and defect rates of the head and body were assessed at late stages to compare cohorts of embryos (Karunamuni et al., 2015) . In this study, analysis of these parameters was conducted for varying concentrations of betaine and choline with alcohol exposure (Table 2,  Table S1 ), revealing that betaine was able to improve survival and reduce defect rates at a lower concentration (5 lM) than choline (100 lM). Thus, our subsequent analyses of cardiac development and DNA methylation focused on betaine as a rescue agent. In our earlier study (Karunamuni et al., 2015) , we used optical coherence tomography (OCT) imaging technology that allowed us to rapidly capture data and streamline analysis to demonstrate and quantify the different cardiac defects associated with EtOH exposure. This is now the first OCT study to investigate the efficacy of a lowdose supplement (betaine) in preventing PAE-associated heart defects. These findings could have the potential to significantly impact public health policy related to prenatal nutrition recommendations.
MATERIALS AND METHODS

Ethics Statement
Institutional Animal Care and Use Committee (IACUC) approval was not required for this study which involves the use of avian embryos that were collected at Embryonic Day 8. Quail embryos typically hatch at Embryonic Day 17. According to IACUC guidelines at Case Western Reserve University, the Policy on the use of avian embryos states that "If embryos will be sacrificed prior to 3 days before hatching, the research will not be subject to IACUC review."
Ethanol Exposure and Betaine Supplementation
Fertilized quail eggs (Coturnix coturnix communis; Boyd's Bird Company, Inc., Pullman, WA) were incubated in a humidified incubator (G.Q.F. Manufacturing Co., Savannah, GA) at 38°C until Hamburger and Hamilton (HH) stages 4 to 5 (gastrulation (Hamburger and Hamilton, 1992) ), at which stage the embryo has been found to be susceptible to the induction of CHDs (Karunamuni et al., 2014 (Karunamuni et al., , 2015 Serrano et al., 2010) . Solutions were injected into the egg using an insulin needle (28 gauge), and holes were sealed with tape before eggs were re-incubated. EtOH-exposed eggs were injected with 40 ll of 50% EtOH (v/v with saline), and control eggs were either injected with 40 ll of saline or left intact. EtOH dosage was based on previously published protocols (Bruyere and Kapil, 1990; Bruyere et al., 1994; Fang et al., 1987; Karunamuni et al., 2014 Karunamuni et al., , 2015 Serrano et al., 2010) as being equivalent to 1 binge-like drinking episode in humans (4 to 5 standard drinks on 1 occasion) and has reliably produced FAS-associated CHDs (Karunamuni et al., 2014 (Karunamuni et al., , 2015 Serrano et al., 2010) . The EtOH dose (40 ml of 50% EtOH [v/v] ) injected into an 8.8 ml (wet volume) quail egg is equivalent to 0.179% (g/dl) or 40 mM. Intoxicated individuals have a blood alcohol content (BAC) of 0.08 to 0.268% (g/dl) (NIAAA, 2004; Urso et al., 1981) . Thus, the dose we use is within range of BACs detected after 1 bout of heavy alcohol consumption. The dose experienced by our avian embryos is relevant to the dose experienced by a human fetus because alcohol passes easily through the placenta and the BAC of the mother would be similar to that experienced by the embryo/fetus. Investigators using the pregnant sheep model concluded that "the placenta does not significantly retard maternal/fetal transfer of EtOH" after comparing the alcohol levels in the blood of the mother sheep and the fetal sheep (Lafond et al., 1985; Ng et al., 1982, p. 41) .
Betaine-supplemented eggs were injected at gastrulation with 40 ll of 50% EtOH along with varying concentrations of betaine (Table 2 ) (Sigma Aldrich, St Louis, MO) to establish a dose-response curve after which an optimal dose of betaine (5 lM in the 40 ll) was chosen based on improved survival and head/body defect rates at late stages (HH stage 34). This is equivalent to a dose of 0.023 lM. A single injection of 40 ll of this mixture of 50% EtOH and 5 lM betaine was used per egg in the subsequent rescue experiments.
Statistical Analyses
The statistical analysis of the data in the Tables is explained in the Results section.
Optical Clearing
Cohorts of control, EtOH-exposed, and betaine-supplemented embryos were allowed to develop until HH stage 34, when the heart would normally acquire a 4-chambered morphology and developed cardiac valve leaflets. Hearts from the different exposure groups were dissected, incubated in 0.5 M potassium chloride (to relax the heart muscle), washed in phosphate-buffered saline (PBS), and fixed in 10% formalin overnight. Samples were then optically cleared using the Clear-T protocol, involving a series of formamide solutions (20% formamide for 30 minutes, 40% for 30 minutes, 80% for 2 hours, 95% for 30 minutes, and then overnight) (Karunamuni et al., 2015; Kuwajima et al., 2013) , before being imaged with the OCT system.
Optical Coherence Tomography Imaging of Hearts
Embryos were imaged using a custom-built spectral-domain OCT system with a quasi-telecentric scanner Rollins, 2005, 2007; Ma et al., 2014; Peterson et al., 2014) . The OCT light source is a superluminescent diode centered at 1,310 nm with a full width at half-maximum bandwidth of 75 nm. The OCT system uses a linear-in-wavenumber spectrometer and a line-scan camera with a line rate of 47 kHz (Hu and Rollins, 2007) .The axial resolution as well as the lateral resolution is approximately 10 lm in tissue (Hu and Rollins, 2007) . Thus, OCT imaging offers high spatial resolution and extremely high temporal resolution, while providing appropriate penetration depth (1 to 3 mm in cardiac tissues) (Drexler and Fujimoto, 2015) . For this study, embryo hearts were placed in 95% formamide in a small plastic dish for imaging. OCT volumes (1,000 lines/frame, 400 frames/volume, 4 mm 9 4 mm field of view) were recorded for each sample. For each heart, 3 volumes were taken: two from the front focusing on the great vessels and the atrioventricular (AV) valves, respectively, and one from the back also focusing on the AV valves.
Postprocessing and Analysis of Optical Coherence Tomography Images
Customized MATLAB programs (MathWorks, Natick, MA) were used to generate OCT images from the raw data, which were then analyzed with AMIRA software (FEI Visualization Sciences Group, Burlington, MA). The frontal plane was used for the identification of septal defects, while the transverse plane was used for the identification of outflow defects and the measurement of vessel diameters and septum thicknesses, as described previously (Karunamuni et al., 2015) . Our co-author JPS, a pediatric cardiologist with expertise in echocardiography, also analyzed the OCT images to confirm identification of heart defects. Vessel diameters were measured proximally after the immediate branching into the individual arteries. The cardiac valves were manually segmented in AMIRA to measure their volumes. Statistical analyses of vessel diameters and valve volumes were performed with analysis of variance (ANOVA) using MATLAB.
5-Methylcytosine Immunofluorescence
HH stage 12 quail embryos (3 controls, 3 EtOH-exposed embryos, and 3 betaine/EtOH-exposed embryos) were collected and fixed in 4% paraformaldehyde, washed in PBS, and incubated in sucrose overnight. This stage corresponds to a time when cardiac neural crest cells (CNCCs) are migrating laterally from the dorsal neural tube toward the circumpharyngeal ridge. Embryos were then cryo-sectioned transversely (10 lm thickness). Sections were chosen for each embryo at similar transverse levels, caudal to the end of the otic vesicle (regions of CNCC migration), and washed 3 times in PBS for 5 minutes each. Sections were incubated at room temperature with blocker (0.1% Triton-X, 5% normal goat serum, diluted in PBS) for 1 hour to permeabilize tissue and then overnight at 4°C with the primary antibody (anti-5-methylcytosine antibody [Genway Biotech, San Diego, CA], diluted 1:1,000 in blocker). Sections were then washed in PBS 3 times for 5 minutes each and incubated with the secondary antibody (Alexa Fluor 488 Goat Anti-mouse [Moleular Probes, Eugene, OR], diluted 1:1,000 in blocker) for 2 hours at room temperature. Sections were washed again in PBS and coverslipped using DAPI-containing mounting medium (Vector Labs, Burlingame, CA), after which they were imaged using an inverted Nikon Diaphot 200 microscope and QCapture Pro software (QImaging, Surrey, BC, Canada). ImageJ (National Institutes of Health, Bethesda, MD) was used to count 5-methylcytosine-positive cells and also measure the intensity of the DAPI-positive nuclei. Relative numbers of 5-methylcytosine-positive cells were compared among the 3 cohorts using ANOVA.
RESULTS
At later developmental stages (HH stage 34, 4-chambered heart), control embryos, either uninjected or saline-treated, had high survival rates (89%) and low defect rates (0%) of the head and body ( Table 1 ) consistent with our previously published findings. In contrast, EtOH-injected embryos had low survival rates (46%) and high defect rates (50%), often presenting with anomalies in eye development and cranial/ chest wall closure as we previously found (Karunamuni et al., 2015) .
The overall difference in the numbers of survivors among the 3 groups, uninjected, saline, or EtOH-injected, was statistically significant using both the Fisher's exact test (p = 2.075 9 10
À13
) and the chi-square test (p = 2.56 9 10 À12 ) as was the difference in the numbers of survivors with defects from these 3 groups. To examine where the difference came from, we performed an equivalence test (Chow et al., 2007) for the difference e between the 2 control groups: "uninjected" and "saline" treatment groups, and Fisher's exact and proportional tests for all possible pairs of the 3 groups. The equivalence test supported the bioequivalence of the "uninjected" versus "saline" groups; specifically, it rejected the null hypothesis |e| ≥ d in favor of the alternative hypothesis |e| < d for a small d = 0.005 at the significance level of a = 0.05. By both the Fisher's exact and proportion tests (i.e., 2 types of tests) with a Bonferroni correction for the multiplicity, we found that the numbers of survivors, and the numbers of survivors with defects (i.e., 2 types of measures), were strongly and significantly different between the group treated with "EtOH" and any of the 2 controls groups: "uninjected" and "saline" (i.e., 2 different contrasts) with p < 0.00017 for all 8 comparisons (8 = 2 contrasts*2 tests*2 measures), but not between the 2 controls (p = 1 by both tests).
In summary, injecting EtOH strongly and statistically affected the embryos in comparison with injecting saline or providing no injection (Table 1) .
A dose-response curve (Table 2) was obtained for the methyl donor betaine which was introduced with the EtOH injection at gastrulation stages (HH stages 4 to 5). The lowest optimal betaine concentration in EtOH was revealed to be 5 lM (calculated for the 40 ll injection), which induced improvements in both survival and defect rates for the embryos (73 and 27%, respectively). To examine the toxicity of this concentration, the 5 lM betaine dose was injected in only saline (n = 26 embryos), resulting in survival and defect rates that fell within control ranges (81 and 0%, respectively). The methyl donor choline, from which betaine is metabolized, was also used to supplement the EtOH-exposed embryos with similar positive effects but at higher nontoxic concentrations (100 lM) (Table S1 ). Further experiments were therefore conducted using betaine at a concentration of 5 lM because low-dose supplements could present less risk for the expectant mother.
Embryos from 3 experimental groups ("control," "EtOH," and "EtOH + betaine") were then collected so that their hearts could be analyzed for late-stage cardiac defects using OCT. We chose to harvest a smaller cohort of EtOHexposed embryos as they still presented with a full complement of defects and significantly different phenotypes in comparison with control embryos; 98% (42/43) of the controls developed normal hearts with no apparent defects, and 18 (62) 4 (22) EtOH, ethanol. 5 lM of betaine (in bold) was the lowest dose that provided optimal rescue of EtOH impacted survival and defect rates. the 1 abnormal embryo exhibited abnormal ventricular rotation that was not found in any of the other groups (Table 3) . In contrast, only 27% (3/11) of the EtOH-exposed group had normal hearts. The most prevalent EtOH-induced cardiac defect in this cohort was the absence of certain great vessels at a level proximal to the heart where they would normally branch (Table 3) , involving the right pulmonary artery (RPA), the right brachiocephalic artery (RBA), or both ( Fig. 2A,B) . Other associated anomalies included abnormal AV valve morphologies (Fig. 3A-D) , hypertrophic right ventricles (thicker walls with smaller right ventricular chambers) (Fig. 4A,B) , ventricular septal defects, and misalignment of the aorta. With betaine supplementation however, 89% (32/36) of EtOH-exposed embryos developed normal hearts, indicating a partial rescue of cardiac defects even in the presence of EtOH. These embryos did not develop abnormal AV valves or ventricular septal defects, and also presented with reduced prevalence of missing vessel defects and hypertrophic right ventricles (Table 3) . One EtOH + betaine embryo developed a tiny collateral artery at the level where we analyzed the great arteries. These findings suggest that betaine can protect substantially against EtOH-induced impairments in the right ventricle and great vessel morphogenesis, as well as AV valve and interventricular septum (IVS) formation.
Previously, we were able to use OCT to rapidly delineate and quantify subtle, complex anomalies in cardiac structures that had been affected by EtOH (Karunamuni et al., 2015) , including great vessel diameter (lumen and outer), left AV valve volume, and IVS thickness. In this study, we used OCT in a similar way to economically and rapidly determine the effect of betaine on these parameters in the PAE model. In comparison with both the controls and EtOH + betaine embryos, EtOH-exposed embryos had significantly reduced lumen diameters (Fig. 2) for the left pulmonary artery (LPA), RPA, left brachiocephalic artery (LBA), RBA, and aortic arch (AA) (24.4, 36.0, 14.8, 28 .5 and 20.6% decrease, respectively, compared to controls, p < 0.05). However, only the LPA, RPA, and AA displayed significant reductions in outer diameter after EtOH exposure (14.9, 22.0, and 14.7% decrease, respectively, compared to controls, p < 0.05). In contrast, there was no significant difference in the lumen or outer diameter for the great vessels in the EtOH + betaine embryos compared to control specimens (Fig. 2) . Furthermore, EtOH-exposed embryos had significantly reduced mural, septal, and total AV valvular volumes compared to controls and betaine-supplemented embryos (25.4%, 24.5%, and 25.4% decrease, respectively, compared to controls with p < 0.05) (Fig. 3) . Mural AV valve volumes were not significantly different for the control and EtOH + betaine groups, but septal valvular volumes were significantly increased in the betaine-exposed embryos (14.5% increase compared to controls, p < 0.05). However, there were no significant increases in total valvular volume (8.9% increase compared to controls, p > 0.05) (Fig. 3) . Finally, EtOH-exposed embryos had significantly reduced IVS thicknesses compared to controls and betaine-supplemented embryos (24.7% reduction compared to controls, p < 0.05), but EtOH + betaine-supplemented embryos displayed normalized IVS numbers (Fig. 4) .
For the statistical analysis of the data presented in the first 3 columns of Table 3 , we compared the differences in 3 treat-
terms of the numbers of normal hearts and 7 cardiac defects, and the numbers at the 2 locations (valve defects vs. vessel and septation defects), as well as the number of defects per embryo, in addition to an equivalence test between the numbers of normal hearts from the control (C) and the EtOH + betaine (E + B) groups. Specifically, the bioequivalence between the control group and the EtOH + betaine group in the numbers of normal hearts was found at d = 0.09 and a = 0.05. Although this bioequivalence (d = 0.09) is not as strong as that of the 2 control groups, uninjected and saline, in Table 1 (d = 0.005), it showed that adding betaine helps to reduce cardiac defects in EtOHexposed embryos, which is confirmed by detailed comparisons below. Across the 3 treatments (C, E, E + B), there were 8 comparisons in terms of the numbers of normal heart and 7 cardiac defects. Fisher's exact test with a Bonferroni correction indicated that there were statistically significant differences among the 3 treatments in the numbers of "normal heart," defects due to "missing great vessel" and "abnormal valve morphology" (noted as ** in Column 5 in Table 3 ), and less but still significant differences in the numbers of defects identified as "hypertrophic right ventricle" and "ventricular septal defects" (*). There was no evidence from these data for significant differences in terms of other defects, which may require a larger study to detect.
As there was bioequivalence between the control and EtOH + betaine groups, we reasoned that the differences detected in the 3-treatment comparison should come from the difference between E and E + B groups, or between E and C groups. To confirm this, comparisons between E and E + B were conducted using the Fisher's exact test across the 8 numbers (1 normal and 7 defects) (Table 3) , and also for the numbers (x) of defects per embryo with x = 0, 1, and ≥2. The significant results between E and C would be implied by those between E and E + B (Column 6 in Table 3 ) as the differences between E and C are clearly bigger than those between E and E + B. However, we did compare the overall difference among the 3 groups and both differences between E and C, and between E and E + B groups, using the proportional test for the 2 locations (valve or vessels). In the 8 comparisons, the numbers of "normal hearts" (p = 0.00019), or the numbers of embryos having a "missing great vessel" (p = 0.0049) were found to be clearly significantly different between the E and E + B groups with a Bonferroni correction while the numbers with "abnormal valve morphology" were significantly different but with a larger p-value (0.01018). We then separated defects by location (valve and vessel) and conducted the proportion test for all 3 groups; Fig. 2 . Vessel defects induced by ethanol (EtOH) in HH stage 34 quail embryos. (A) Transverse optical coherence tomography slice in a control embryo depicting the 5 great vessels that typically branch off close to the base of the heart: the left pulmonary artery (LPA), the right pulmonary artery (RPA), the left brachiocephalic artery (LBA), the right brachiocephalic artery (RBA) and the aortic arch (AA). Scale bar = 0.5 mm. (B) Example of vessel defect where there are only 3 vessels at the proximal branching points: the LPA, the LBA, and the AA. (C) Comparison of lumen and outer diameters of the great vessels for control (n = 43), EtOH-exposed (n = 11), and EtOH + betaine-supplemented (Eth + Bet, n = 36) embryos, black bars represent standard error of the mean (SEM). Statistical analysis was performed using standard ANOVA (single factor) using the function of MATLAB. *For the EtOH group indicates statistically significant differences compared to controls or EtOH + betaine group, in both cases p < 0.05. these were significantly different with p-values of 0.000159 and 0.0002368. We hence tested for 2 groups, between E and E + B (p = 0.0277 and p = 0.0255), and between E and C (p = 0.0151 and p = 0.00049) for both valve and vessel defects, respectively. In summary, there is strong statistical evidence that adding betaine reduced the number of a variety of cardiac defects caused by EtOH.
After late-stage cardiac parameters were analyzed, it was apparent that the methyl donor betaine had alleviated the impact of EtOH on cardiac morphogenesis at HH stage 34. These findings raised the question of whether betaine had affected DNA methylation at earlier developmental stages as part of its role as a rescue agent for alcohol exposure. To address this issue, HH stage 12 embryos were collected for each treatment group, corresponding to a time when CNCCs (with crucial roles in cardiac development) are actively migrating away from the dorsal neural tube. Transverse sections were selected from CNCC migration locations (just caudal to the otic vesicle) and stained for the DNA methylation marker 5-methylcytosine (Zhou et al., 2011) . Relative numbers of 5-methylcytosine-positive cells were obtained using ImageJ software and analyzed for comparison. In comparison with controls, there was a trend toward reduced levels of 5-methylcytosine staining in the EtOH-exposed group with measurements being similar between the control and betaine-supplemented embryos (Fig. 5) . A statistically significant difference was detected between the EtOHexposed and the EtOH plus betaine groups (p < 0.05) with the addition of betaine bringing the levels to control levels. This is consistent with early-stage DNA methylation being altered after EtOH exposure and could contribute to the progression of defects observed at later stages. The details of which cell types and which genes are affected by the methylation changes will be the subject of future studies.
DISCUSSION
In brief, the beneficial effects of supplementation of the methyl donor betaine in our avian model of PAE were manifold (Fig. 6) . Within 24 hours of gastrulation (injection stage), immunostaining for the DNA methylation marker 5-methylcytosine in regions of active CNCC migration confirmed that cellular methylation levels were reduced after alcohol exposure but normalized with the co-introduction of (E) Comparison of mural, septal, and total valvular volumes for control (n = 43), EtOH-exposed (n = 11), and EtOH + betaine-supplemented (Eth + Bet, n = 36) embryos, black bars represent SEM. *For EtOH group indicates statistical significance compared to controls or EtOH + betaine group, p < 0.05. Statistical analysis was performed using standard ANOVA (single factor) using the function of MATLAB. *For EtOH + betaine group indicates statistical significance compared to controls, p < 0.05.
betaine. This finding suggests that the exogenous addition of betaine protected DNA methylation even with EtOH exposure. At later developmental stages (4-chambered heart), betaine/alcohol-exposed embryos showed prominent improvements in survival rates and defect rates of the head and chest wall. Furthermore, these embryos presented with more normal hearts than the group exposed to alcohol alone, with reductions in cardiac defects such as absent vessels, abnormal AV valve morphologies, and ventricular defects. Cardiac parameters such as IVS thickness, great vessel diameters, and AV valve volumes in the betaine/alcohol group were also normalized, with the exception of the septal AV leaflet volume which was increased compared to controls. This mild leaflet enlargement did not appear to negatively impact embryo survival or other features of development, and could be the result of compensatory mechanisms that were activated in response to the EtOH insult.
Despite these novel and promising results, it is important to consider the limitations of the study. Our study design was limited to 1 time point of betaine administration at the same time as the EtOH exposure. In an ideal situation, the mother would already be on a regimen including betaine supplements before having a binge drinking episode in the early stages of pregnancy. However, our investigations revealed that 2 separate egg injections significantly impaired embryo health and survival, thus necessitating reliance on a single injection of the mixture of alcohol and betaine at gastrulation. Thus, we did not test whether preconception intake of betaine might be even more effective in preventing congenital defects. In our model, supplementing with methyl donors such as choline or betaine improved alcohol-impacted survival rates and defect rates approaching but not achieving the numbers for control specimens, which suggests that another mechanism crucial to embryogenesis may also have been deleteriously affected by alcohol. The details of all the mechanisms by which betaine had its positive effects on preventing alcohol-induced defects were not investigated here. These considerations do not however change the fact that betaine, a naturally occurring alternative to folate, had positive effects on reducing PAE-related defects and should be investigated further in other animal models and eventually the clinical setting.
Processes other than DNA methylation may also have been impaired by EtOH exposure. One possibility is histone modification. In vitro studies by Zhong and colleagues (2010) revealed that high levels of EtOH exposure in cardiac progenitor cells altered both histone H3 acetylation and subsequent expression of genes related to heart development. Other researchers found that EtOH exposure in fetal neuronal stem cells altered levels of H3K4me3 and H3K27me3, which can affect transcription and expression of genes underlying the progression of FASD-associated defects (Veazey et al., 2013) . Another promising line of investigation could target mechanisms of oxidative stress. Typically, reactive oxygen species (ROS) are by-products of normal cellular metabolism in the mitochondria and cytoplasm. However, the presence of environmental stressors or toxins such as EtOH can result in elevated ROS levels, which can overwhelm endogenous antioxidant defenses and lead to cell damage and death through the oxidation of DNA, proteins, and lipids (Brocardo et al., 2011) . Betaine has also been shown to repair damage to sulfur containing amino acids such as SAM (Zhang et al., 2016) that have direct antioxidant activities as ROS scavengers. So while betaine does not serve as an antioxidant itself, it indirectly promotes antioxidant activities. Furthermore, CNCCs, which are crucial to normal heart development and function, have been found to exhibit low levels of antioxidant enzymes and are thus particularly vulnerable to increased oxidative stress (Davis et al., 1990; Morgan et al., 2008; Smith et al., 2014) . It has also been well documented that the introduction of antioxidants in models of PAE can alleviate certain alcoholrelated defects due to their ability to quench ROS and other free radicals (Brocardo et al., 2011; Chen et al., 2013; Joya et al., 2015; Reimers et al., 2006) . Examples of such compounds with antioxidant capacity include vitamins C and E, sulforaphane, catalase, superoxide dismutase, epigallocatechin gallate, and glutathione. It might therefore be advantageous to consider combining methyl donors and antioxidants in a multisupplement that could provide enhanced protection against PAE-associated birth defects. This method of using avian embryos and OCT allows rapid and economical screening for compounds and combinations of compounds with potential to prevent PAE-induced defects.
Betaine has many roles in addition to serving as a methyl donor for DNA and protein methylation that may explain its effect in preventing CHDs (Day and Kempson, 2016) . For example, the downstream product SAM can be synthesized to phosphatidylcholine by the enzyme phosphatidyethanolamine N-methyltransferase, leading to membrane integrity and enhanced signaling. As a methyl donor for the folate cycle, betaine could also impact purine and pyrimidine synthesis that is important for DNA and RNA synthesis, crucial during embryogenesis.
In conclusion, this is the first study to demonstrate that supplementation with betaine, found naturally in several foods, can alleviate many of the negative effects of PAE, such as the prevention of CHDs which often have a devastating impact on survival and quality of life. These findings may potentially inform prenatal nutrition recommendations for women who have ingested or are likely to ingest alcohol in the early stages of pregnancy, women who have a deficiency Relative levels of 5-methycytosine were assessed as the number of 5-methylcytosinepositive cells in the section normalized to the total intensity of DAPI staining in the same section, as quantified by ImageJ software. 5-Methylcytosine (5-MeC) levels were reduced with ethanol (EtOH) exposure, but with coadministration of betaine, 5-MeC levels were closer to control (untreated) levels. Statistical analysis was performed using standard ANOVA (single factor) using the function of MATLAB. *Indicates significance compared to EtOH + betaine group, with p < 0.05. NT, neural tube. in folic acid cycle enzyme activity, or those who are more vulnerable to altered folic acid levels. The use of methyl donors such as betaine could also have therapeutic value in the ongoing development of a multisupplement for further protection against FASD birth defects. This approach does not diminish the need for the continued public education of the community on the risks of alcohol exposure during any part of gestation (Green et al., 2016; Williams and Smith, 2015) .
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